# Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting

> **NCT02104154** · — · TERMINATED · sponsor: **Samsung Electronics** · enrollment: 32 (actual)

## Conditions studied

- Hepatic Disease

## Interventions

- **DEVICE:** Samsung LABGEO PT10 Hepatic Panel

## Key facts

- **NCT ID:** NCT02104154
- **Lead sponsor:** Samsung Electronics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** To conduct interim analysis and assess whether assay changes are recommended.
- **Last updated:** 2015-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104154, "Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02104154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*